Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

NCT02183701 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

715

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan
DRUG: Losartan + Hydrochlorothiazide
DRUG: Placebo

Sponsor

Boehringer Ingelheim